42 results on '"Maughan T"'
Search Results
2. CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method
3. CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method
4. Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers
5. A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS
6. Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer
7. Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
8. Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer
9. Patient eligibility screening and nursing workload in a trials active cancer centre
10. Assessing cancer trial complexity and its impact on workload
11. A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?
12. Attitudes to chemotherapy for the older patient with cancer
13. Clinical impact of a national lymphoma review panel - A pilot study
14. Audit of clinical trial eligibility and recruitment rates in a single speciality cancer centre
15. Dual inhibition of epidermal growth factor and insulin-like 1 growth factor receptors reduce intestinal adenoma burden in the Apcmin/+ mouse
16. The attitudes of 1066 patients with cancer towards participation in randomised clinical trials
17. Small cell oesophageal carcinoma: an institutional experience and review of the literature
18. A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study
19. Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial
20. A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study
21. Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging?
22. Definitive chemoradiation in patients with inoperable oesophageal carcinoma
23. Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial
24. Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer
25. Adjuvant chemotherapy for colorectal cancer
26. Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome
27. Effects of impaired renal function on the pharmacokinetics of raltitrexed (Tomudex ZD1694)
28. Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial.
29. Strengthening clinical cancer research in the United Kingdom.
30. Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience.
31. Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer.
32. Tumour concentrations of flavone acetic acid (FAA) in human melanoma: comparison with mouse data.
33. High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer: poor response rate in unselected patients.
34. Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma.
35. Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer.
36. Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone.
37. Lack of an association between gallstone disease and bilirubin levels with risk of colorectal cancer: a Mendelian randomisation analysis.
38. Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer.
39. A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS.
40. Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study.
41. 5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation.
42. CA125 in ovarian tumour tissue at second laparotomy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.